NOTHING DISCUSSED IN THIS PODCAST IS MEDCAL ADVICE
In this weeks episode of Bioactive Riley (@cannabichem) talks with Chris Witowski the CEO and cofounder of the biotech company Psilera investigating new psychedelic substances for the treatment of conditions like anxiety, depression, and PTSD.
Chris discusses the general pipeline for how Psilera goes about investigating new drug candidates as well as the advantages to non-hallucinogenic psychedelic drugs.
Thanks for listening and subscribing to this channel- mad love
Reach Chris and the rest of the Psilera team at:
info@psilera.com
twitter: @Psilera
IG: @Psilera
Papers discussed in this episode:
"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB" https://www.nature.com/articles/s41593-023-01316-5
